Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Total Liabilities (2016 - 2026)

Eastman Chemical (EMN) has disclosed Total Liabilities for 18 consecutive years, with $9.1 billion as the latest value for Q1 2026.

  • For Q1 2026, Total Liabilities rose 1.21% year-over-year to $9.1 billion; the TTM value through Mar 2026 reached $9.1 billion, up 1.21%, while the annual FY2025 figure was $8.8 billion, 5.76% down from the prior year.
  • Total Liabilities hit $9.1 billion in Q1 2026 for Eastman Chemical, up from $8.8 billion in the prior quarter.
  • Across five years, Total Liabilities topped out at $9.8 billion in Q1 2022 and bottomed at $8.8 billion in Q4 2025.
  • Average Total Liabilities over 5 years is $9.3 billion, with a median of $9.3 billion recorded in 2025.
  • Year-over-year, Total Liabilities decreased 5.98% in 2022 and then rose 2.83% in 2024.
  • Eastman Chemical's Total Liabilities stood at $9.4 billion in 2022, then decreased by 3.48% to $9.1 billion in 2023, then rose by 2.83% to $9.4 billion in 2024, then fell by 5.76% to $8.8 billion in 2025, then increased by 3.56% to $9.1 billion in 2026.
  • According to Business Quant data, Total Liabilities over the past three periods came in at $9.1 billion, $8.8 billion, and $9.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.